Home

Advertisement

thenewsoud [entries|archive|friends|userinfo]
thenewsoud

[ userinfo | livejournal userinfo ]
[ archive | journal archive ]

Tumor Necrosis Factor Alpha Inhibitors for Dermatologic Diseases [Jul. 6th, 2008|04:02 pm]
[Tags|]




Psoriasis


Psoriasis is a chronic, inflammatory disease which can affect the skin, tendons, ligaments, and joints (Gottlieb, 2001; Gottlieb & Bos, 2002; Lebwohl, 2003). It has a multifactorial inheritance in which several genes interact with environmental factors to produce varying degrees of severity. Prevalence rates range from 0.5% to 4.6% depending on the country and race (Lebwohl, 2003). It more commonly affects Caucasians and patients living at higher latitudes (Lebwohl, 2003). Although it is not a life-threatening condition, it can lead to significant impairment and psychological stress. Patients who are severely afflicted can have up to 100% body surface area involvement.

There are several clinical variants of psoriasis, including plaque, guttate, erythrodermic, and pustular (Lebwohl, 2003). Plaque type is the most common form, representing 80% of cases, while guttate, erythrodermic, and pustular account for 10%, 3%, and 3% of patients respectively. Cutaneous lesions usually precede joint disease in 70% of patients with psoriasis.

Psoriatic arthritis, a seronegative arthopathy, can affect upwards of 42% of patients with psoriasis (Lebwohl, 2003). Several forms exist, including polyarticular, oligoarticular, distal interphalangeal, arthritis mutilans, spondylitis, and sacroiliitis. Like rheumatoid arthritis, psoriatic arthritis can lead to joint deformities, disability, and increased mortality.Pathogenesis

While the entire pathogenesis of psoriasis remains largely unknown, recent discoveries have been made which have elucidated the pivotal role of T cells (Lebwohl, 2003). This discovery was made through the use of severe combined immunodeficiency mouse models and further supported by the dramatic response to agents such as methotrexate, cyclosporin, and denileukin diftitox, all of which modulate T-cell activity (Gottlieb, 2001). This process begins with the presence of antigens, which cause the maturation of Langerhans cells and the migration of antigen-presenting cells (APC) to the lymph node. Once in the lymph node, the APCs interact with naEFve T cells, causing T-cell activation and subsequent T-cell proliferation. Some of these proliferating T cells are memory T cells, which ultimately migrate to the inflamed target areas of the skin. When these T cells are activated, they will release type 1 cytokines (Th1), such as interferon gamma, IL-2 and IL-12, and TNF (Gottlieb, 2001; Gottlieb & Bos, 2002). These cytokines are responsible for keratinocyte proliferation and lack of maturation, and vascular changes characteristic of psoriasis.Treatment

Three broad categories of treatment options exist for psoriasis, including topical modalities, phototherapy, and systemic therapy (Lebwohl, 2003). Topical treatments are effective for patients with mild-to-moderate psoriasis, while phototherapy and systemic medications are appropriate for more severe cases. These topicals include topical steroids, tar, anthralin, vitamin D analogues, and retinoids.

Phototherapy encompasses treatment with PUVA, broadband and narrowband UVB, and the 308 nm excimer laser (Lebwohl, 2003). Prior to beginning PUVA, laboratory tests, such as antinuclear antibodies, should be performed. This is to ensure that the patient does not harbor undiagnosed collagen vascular disease/photosensitivity. Also, since psoralen, which is ingested prior to UVA exposure, is a photosensitizer and can cause heptotoxicity, liver function tests should be obtained.

In patients afflicted with severe psoriasis, systemic therapies have been effective, but some carry significant side effects (Lebwohl, 2003). Several systemic medications can be used for psoriasis, such as methotrexate, cyclosporin, retinoids, and more recently targeted immunotherapies (biologics). Patients treated with methotrexate must be monitored for bone marrow and hepatic toxicities. Retinoids can cause mucocutaneous side effects, hair loss, nail thinning, and teratogenicity. Cyclosporin use can lead to nephrotoxicity, hypertension, or development of lymphomas with prolonged use; therefore, its use is usually limited to 1 year.

Recently targeted immunotherapies have become popular alternatives for patients with severe psoriasis. These treatments target specific cells, cytokines, or interactions to achieve remission (Lebwohl, 2003). Not only are these alternatives effective, but they have a more favorable side effect profile than the traditional systemic agents. Alefacept (Amevive®) and denileukin diftitox (Ontak®) are fusion proteins which eliminate activated T cells by targeting the interaction between LFA3 on APC and CD2 on T cells, and by binding to IL2 receptor (CD25) to release diphtheria toxin, respectively. Inhibition of T-cell activation/proliferation has been achieved with several therapies, including a monoclonal antibody to anti-CD4, anti-CD80, anti-CD25 (daclizumab), anti-CD11a (efalizumab), and anti-CD2 (siplizumab). Also, CTLA4Ig is a fusion protein which binds to CD80 and CD86 on APCs to inhibit T-cell activation. Immune deviation has been achieved through the use of IL4 and 10, which are type 2 cytokines (Th2) that counteract the Th1 predominance found in psoriasis. Finally, inhibition of cytokines is accomplished with infliximab (Remi cade®), a chimeric mouse-human monoclonal antibody which inhibits TNFα (see Figures 1 & 2); etanercept (Enbrel®), a fusion protein which inhibits TNFα (see Figures 3-6); adalimumab (Humira®), a fully humanized monoclonal antibody to TNFα; and anti-IL8.

Figure 1.  (click image to zoom)

Severe psoriatic involvement of most of the trunk, prior to the start of infliximab therapy.      

Figure 2.  (click image to zoom)

Resolution of psoriasis, after completion of infliximab therapy.      

Figure 3.  (click image to zoom)

Significant psoriatic involvement of the hands, prior to the use of etanercept.      

Figure 4.  (click image to zoom)

Resolution of psoriasis, after 16 weeks of etanercept therapy.      

Figure 5.  (click image to zoom)

Large psoriatic plaques on the breast, prior to starting etanercept.      

Figure 6.  (click image to zoom)

Complete resolution of psoriatic plaques, after 16 weeks of etanercept.      

Infliximab (Remicade®)

Infliximab is a chimeric monoclonal IgG antibody which inhibits TNFα activity and triggers complement mediated lysis of TNFα expressing cells in vitro (Gottlieb, 2001; Gottlieb & Bos, 2002; LaDuca & Gaspari, 2001; Lebwohl, 2003; Victor & Gottlieb, 2002; Williams & Griffiths, 2002). It is made from human constant and mouse variable regions of IgG. It neutralizes soluble and blocks membrane-bound TNFα. It is FDA approved for the treatment of Crohn's disease and rheumatoid arthritis (RA) at intravenous doses of 5 mg/kd and 3 mg/kg respectively. The infusion is given over at least 2 hours and has a half life of 8 to 10 days (Williams & Griffiths, 2002). Crohn's disease without fistulas is treated with one dose of infliximab at 5 mg/kg, while the presence of fistulas requires three doses of 5 mg/kg at weeks 0, 2, and 6. RA is treated with 3 mg/kg at weeks 0, 2, 8, and every 8 weeks thereafter.

It was discovered that infliximab was effective in treating psoriasis after a patient with recalcitrant Crohn's and psoriasis was treated with infliximab for her Crohn's (LaDuca & Gaspari, 2001; Victor & Gottlieb, 2002). After the infusion, not only did her Crohn's improve, but also her psoriasis. In a randomized double blind placebo controlled trial, 33 patients were randomized to a placebo arm, a 5 mg/kg arm, or a 10 mg/kg arm and treated on weeks 0, 2, 6 (Chaudhari et al., 2001). Eighty-two percent of patients in the 5 mg/kg arm, 91% of patients in the 10 mg/kg arm, and 18% of patients in the placebo arm achieved a greater than 75% improvement on Psoriasis Index and Severity Score (PASI) after 10 weeks. Treatment began working within 2 weeks and sustained this improvement for more than 6 months. Immunohistochemical staining showed decreased epidermal inflammation and normalization of keratinocyte differentiation. No serious adverse effects were noted.

Phase II open label data showed that 55% of patients with psoriasis treated with infliximab retained a 50% or greater reduction in the original PASI scores after 26 weeks, with no further infusions (Gottlieb, Chaudhari, Mulcahy, Dooley, & Baker, 2003).

Infliximab was also successful in the treatment of pustular psoriasis, a severe, debilitating, and recalcitrant variant of psoriasis. Elewski (2002) treated two patients with infliximab 5mg/kg on weeks 0, 2, and 6. The patients tolerated the infusion well without any side effects. Clearance began within the first few days after the first infusion with continued improvement until complete clearance. This complete clearance was maintained for 10 weeks after the last infusion. Newland, Weinstein, and Kerdel (2002) reported one case of pustular psoriasis treated successfully with one infusion of infliximab 5 mg/kg. Complete resolution of the pustules occurred by day 4. The infusion was well tolerated without any side effects.

In a 6-month trial, 12 patients with recalcitrant psoriatic arthritis were treated with infliximab 5 mg/kg on weeks 0, 2, 6, 14, 22 along with their previous treatments of steroids and methotrexate (Provenzano, Termini, Le Moli, & Rinaldi, 2003). No infusion reactions were noted. Two patients were withdrawn from the study, one for angina pectoris and one for pulmonary malignancy, which were not considered a result of the infliximab infusions. Significant improvement was noted in all patients.

An open label pilot study was conducted with 21 patients with recalcitrant spondyloarthropathy, 9 of which had psoriatic arthritis (Van Den Bosch et al., 2000). They were treated with infliximab 5 mg/kg at weeks 0, 2, 6, along with methotrexate. Rapid and significant improvement was noted in all patients without any significant side effects. PASI scores showed significant improvement at day 14 compared to baseline, and this improvement was sustained at day 84. Global and peripheral assessment of psoriatic arthritis showed significant improvement in all areas at day 14 compared to baseline, and this significant improvement was maintained at day 84.

Drawbacks are few and include headache, diarrhea, rash, pharyngitis, rhinitis, cough, upper respiratory infection, and urinary tract infection (LaDuca & Gaspari, 2001; Lebwohl, 2003; Mease, 2002; Provenzano et al., 2003; Van Den Bosch et al., 2000; Williams & Griffiths, 2002). Rare instances of more severe side effects have occurred, such as reactivation of pulmonary tuberculosis, aseptic meningitis, sepsis, and development of anti-dsDNA and systemic lupus. Keane et al. (2001) reported 70 cases of TB developing after the use of infliximab, 40 of which had extrapulmonary disease. The incidence of TB with infliximab is much higher than with etanercept. This reactivation of TB has been attributed to immune system disruption, manifested as the failure of granulomas to compartmentalize the bacilli, and inhibition of macrophage apoptosis after the use of infliximab. Patients are required by the Food and Drug Administration to have a negative purified protein derivative (PPD) test and negative chest radiograph prior to starting infliximab therapy. There is also concern of long-term development of antibodies to the drug. In patients with Crohn's treated with repeated infusions of infliximab, 13% developed antibodies against the medication (Tan, Gordon, Lebwohl, George, & Lebwohl, 2001). The presence of these antibodies has lead to the loss of clinical efficacy, the development of infusion reactions, chest pain, bronchospasm, and anaphylactic shock. The rate of antibody formation is inversely related to dose and decreases with the addition of low-dose methotrexate (Lebwohl, 2003). How this will translate in patients with psoriasis remains to be seen. Infusion reactions, such as anaphylaxis and bronchospasm, can occur rarely, and can be treated by slowing the infusion rate and pretreating with antihistamines or steroids. Relative contraindications to the use of infliximab include congestive heart failure, demyelinating disorders, lupus, lymphoma/malignancy, antibody formation to infliximab, hypersensitivity to murine products, and sepsis. Infliximab is a pregnancy class B drug.Etanercept (Enbrel®)

Etanercept is a recombinant human TNFα receptor fusion protein, which consists of the extracellular domains of two TNFα receptor p75 receptors and the constant (Fc) region of IgG1, which inhibits soluble TNFα. In contrast to infliximab, etanercept binds to and inhibits only soluble TNFα (Gottlieb, 2001; Gottlieb & Bos, 2002; LaDuca & Gaspari, 2001; Lebwohl, 2003; Victor & Gottlieb, 2003; Williams & Griffiths, 2002). It is FDA approved for the treatment of adult rheumatoid (RA) and psoriatic arthritis (PA) at doses of 25 mg twice a week administered subcutaneously.

It was noted that in the treatment of patients with PA, their psoriasis improved as well (Davison, Bunker, & Basarab, 2002; Galadari, Fuchs, & Lebwohl, 2003; Iyer, Yamauchi, & Lowe, 2002; Kurschat et al., 2001). Mease et al. (2002a) enrolled 60 recalcitrant psoriatic arthritis patients in a double-blind placebo-controlled study comparing subcutaneous injections of etanercept 25 mg twice a week to placebo. Patients continued on metho trexate. After 12 weeks, 87% of etanercept-treated patients versus 23% of placebo-treated patients responded significantly based on the Psoriatic Arthritis Response Criteria (PsRC). Using the American College of Rheumatology criteria (ACR20), statistically significant improvement was noted in 73% of the etanercept-treated patients and 13% of the placebo-treated patients at 12 weeks. Also, 26% of the etanercept-treated patients had a 75% improvement in PASI scores, while none of the placebo patients improved. Only 20 of the patients reported side effects, namely injection site reactions, but no significant side effects were noted. After 4 months of followup, five patients had no joint pain and 55 had only mild symptoms. In the phase III trial of etanercept for PA, there was a median improvement in PASI in 33% in the etanercept group and none in the placebo groups (Mease et al., 2000a).

In a subsequent 12-week double-blind placebo-controlled study of etanercept for psoriasis, 70% of patients given etanercept had improvement in their PASI scores (Gottleib, Matheson, Lowe, & Zitnik, 2002). Fifty-six percent of patients treated with etanercept and 5% of placebo-treated patients had a 75% reduction in PASI scores at 24 weeks.

The most common side effect was injection site reactions (Gottleib et al., 2002; Mease et al., 2000a; Mease, Goffe, & Betz, 2000b). Other uncommon side effects were upper-respiratory infections, headache, rhinitis, abdominal pain, vomiting, pharyngitis, nausea, gastrointestinal infection, and rash. Antibody formation is less likely to occur in etanercept-treated patients compared to infliximab (Lebwohl, 2003). Thirteen cases of TB reactivation have been reported (Goffe & Cather, 2003; Keane et al., 2001). Unlike infliximab, etanercept-associated TB occurs sporadically and later in the course of treatment. Even though the FDA does not require a negative chest radiograph and PPD, both should be performed. More serious reactions have occurred, including demyelinating disorders, aplastic anemia, allergic reactions, and development of positive ANA, anti-dsDNA, and drug-induced systemic lupus. No malignancies have been discovered during the FDA trials; however, Smith and Skelton (2001) reported seven cases of squamous cell carcinoma occurring in patients with RA treated with etanercept (Smith & Skelton, 2001). It has been found in long-term RA studies using etanercept that the incidence of malignancy was not increased over age-matched controls (Goffe & Cather, 2003). Relative contraindications to use of etanercept include sepsis, malignancy, congestive heart failure, and demyelinating diseases. It is a pregnancy class B drug.  Printer- Friendly Email This

Dermatol Nurs.  2005;17(2):97-108.  ©2005 Jannetti Publications, Inc.
This is a part of article Tumor Necrosis Factor Alpha Inhibitors for Dermatologic Diseases Taken from "Generic Isotretinoin Accutane" Information Blog

link1 comment|post comment

Newly Diagnosed Human Immunodeficiency Virus [Jul. 4th, 2008|11:51 am]
[Tags|]




Newly Diagnosed Human Immunodeficiency Virus


from Southern Medical Journal

Case Report


A 38-year-old Hispanic man with no significant medical history came to the emergency room with complaints of a "10/10" retroorbital headache, photophobia, fevers, and a rash. The patient reported that he was in his usual state of good health until 2 weeks before admission, when he was placed on a 14-day course of TMP-SMZ (Bactrim DS), loratadine (Claritin), and acetaminophen for symptoms of cough, rhinorrhea, and sinus congestion. Despite treatment, symptoms continued. Myalgias, intermittent chills, and subjective fevers developed 1 week before admission. Two days before admission, a diffuse "red rash" and conjunctivitis developed. Treatment with sulfacetamide ophthalmic solution was started the evening before admission. Eye pain intensified after administration of the ophthalmic solution, and the patient had a headache that prompted the emergency room visit.

The patient denied nausea, vomiting, diarrhea, or weight loss. He denied any recent travel, unusual food, or animal exposure and reported that one coworker was ill with pneumonia. He reported being heterosexual and appropriately using a condom during his last sexual encounter 7 months earlier. He denied history of blood transfusion; use of tobacco, alcohol, or intravenous drugs; or homosexual activity. There was no history of medication allergies or previous exposure to TMP-SMZ.

On examination, the patient appeared thin, ill, and in moderate distress. Vital signs were blood pressure 95/54 mm Hg, heart rate 118/min, respiratory rate 22/min, and temperature 101.7°F. Physical examination was notable for nonicteric sclera, marked bilateral conjunctival injection, photophobia, shoddy cervical adenopathy, and lack of meningeal signs. The oropharynx was erythematous without exudate, lesions, or ulcers. Cardiac and lung examinations were normal. There was a diffuse, nonblanching, erythematous, macular eruption over the torso with no evidence of target lesions. There was 1+ pretibial, pitting edema bilaterally. Laboratory values were white blood cell count of 5.1 x 109/L (53% segmented neutrophils, 39% band forms, 7% lymphocytes, and 1% monocytes), hemoglobin 149 g/L, hematocrit 43.7%, and platelets 249 x 109/L. Liver-associated enzyme levels were elevated, with alkaline phosphatase 131 U/L (normal, 38 to 126 U/L), aspartate aminotransferase 103 U/L (normal, 14 to 36 U/L), alanine aminotransferase 111 U/L (9 to 52 U/L), and total bilirubin 8.55 mmol/L. Lumbar puncture revealed clear, colorless fluid with negative Gram's stain, white blood cell count 22 x 109/L (97% lymphocytes, 2% segmented neutrophils, 1% monocytes), protein 0.74 g/L, and glucose 2.66 mmol/L. Serum glucose was 5.66 mmol/L. Electrolytes, prothrombin time, partial thromboplastin time, and urinalysis were normal. Computed tomography of the sinuses and a chest radiograph were unremarkable.

The patient was admitted to the hospital, sulfa-containing medications were discontinued, and intravenous (IV) piperacillin sodium-tazobactam sodium (Zosyn) and IV erythromycin were started, given the clinical picture consistent with sepsis. The infectious diseases and dermatology services were both consulted, and the patient's symptoms were thought to be consistent with those of a hypersensitivity reaction to sulfa drugs. During hospital day 1, he continued to have fevers up to 103°F, with persistent rash, myalgias, and headache. On the second hospital day, a capillary leak syndrome developed, manifested by pulmonary edema, a mild coagulopathy without bleeding, and peripheral edema. Oxygen and supportive measures were used. On hospital day 3, he was afebrile without headache, and the rash was resolving. All blood, urine, and cerebrospinal fluid cultures done on admission remained negative for organisms, and antibiotics were discontinued. He was monitored without recurrence of fever, coagulopathy resolved, liver enzymes normalized, and the chest's appearance on radiographs returned to normal. He was discharged on hospital day 6 in improved health.

After discharge, Lyme electroimmunofluorescence assay, hepatitis serologies, and fungal cultures remained negative. Enzyme-linked immunosorbent assay and Western blot done during hospitalization were positive for HIV, with HIV-1 RNA of 33,313 copies/mL. Initial CD4 count was 483 (21%). The patient was informed of his HIV status. He denied any identifiable risk factors for HIV infection. Treatment was initiated with lamivudine-zidovudine (Combivir) and nelfinavir mesylate. Six months after discharge, his viral load was below the detectable level with a CD4 count of 794 (25%).



This is a part of article Newly Diagnosed Human Immunodeficiency Virus Taken from "Claritin Loratadine 10Mg" Information Blog

linkpost comment

Allergic Rhinitis and Asthma: The Link, The New ARIA Classificat [Jul. 3rd, 2008|11:49 pm]
[Tags|]




Leukotriene Receptor Antagonists in Allergic Rhinitis


Both histamine and cysteinyl leukotrienes are elevated in the nasal secretions of patients with allergic rhinitis. Whereas histamine induces some of the responses that typify allergic rhinitis (e.g. itching and sneezing), other mediators such as cysteinyl leukotrienes are 5000 times more potent than histamine in causing nasal congestion.

In a multicentre, double-blind trial in patients with spring seasonal allergic rhinitis, randomly assigned to once-daily montelukast (10 mg), loratadine (10 mg) or placebo, Meltzer et al..[22] demonstrated that both the daytime and nighttime nasal symptom scores were significantly (P<0.001) reduced with montelukast and loratadine compared with placebo. The quality of life was also improved with montelukast and loratadine versus placebo (P<0.005). In addition, after 2 weeks of treatment, peripheral blood eosinophil counts were significantly (P </=0.001) decreased with montelukast but not with loratadine or placebo.[21] A montelukast-induced reduction in airway eosinophilia was also reported in the sputum of patients with asthma. In another 2-week study.[22] the concomitant use of montelukast and loratadine improved the individual symptoms, composite scores and global evaluations, and rhinoconjunctivitis quality of life. Wilson et al..[23] studied the effects of an LTRA and antihistamine oral combination (montelukast plus cetirizine) in comparison with mometasone, an intranasal steroid. Intranasal steroids are known to be effective for all symptoms of allergic rhinitis. The study showed that the combination of montelukast plus cetirizine produced significant (P<0.05) improvements compared with placebo in the peak nasal expiratory flow rate, nasal oral index, nasal symptoms, nasal itch and blockage, eye symptoms and daily activity score. Importantly, there were no significant differences between mometasone and montelukast plus cetirizine. Furthermore, in a study by Price et al..[24] in patients with asthma and co-morbid allergic rhinitis, the use of montelukast with budesonide as a combination therapy was shown to be superior to doubling the dose of budesonide, both with or without the use of concomitant allergic rhinitis medications.

Therefore, oral drugs such as LTRAs that are effective for both rhinitis and asthma may be a good alternative for those patients who are not compliant with topical drugs. In fact, in the recent One Airway Survey.[8] treating both allergic rhinitis and asthma effectively was a concern raised by respondents to the survey. Almost three out of four patients (73%) responded that they found it difficult to treat both conditions effectively at the same time, and 85% noted concerns about using too many medications to treat the two conditions. The route of administration was also an important consideration among survey respondents, with nearly two-thirds (65%) reporting that they preferred to use oral medication rather than nasal sprays. Therapeutic strategies such as LTRAs thus represent a particular advance in therapy for the considerable numbers of patients with asthma and co-existing allergic rhinitis, and can increase patient compliance and improve the quality of life.

Reprint Address

Correspondence to Prof. Ruby Pawankar, MD, PhD, Department of Otolaryngology, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-Ku, Tokyo 113-8603, Japan Tel/fax: +81 48 597 2861; e-mail: Pawankar_Ruby/ent@nms.ac.jpAbbreviation Notes

ARIA, Allergic Rhinitis and its Impact on Asthma; ICS, inhaled corticosteroid; LTRA, leukotriene receptor antagonistPrevious PageSection 6 of 6Curr Opin Allergy Clin Immunol 4(1):1-4, 2004. © 2004 Lippincott Williams & Wilkins
This is a part of article Allergic Rhinitis and Asthma: The Link, The New ARIA Classificat Taken from "Claritin Loratadine 10Mg" Information Blog

linkpost comment

FDA Approves Oraquick HIV-1/2 Antibody Test, Follistim AQ Cartridge, Viewpoint CK System, and Chewab [Jul. 3rd, 2008|11:50 am]
[Tags|]




FDA Approves Oraquick HIV-1/2 Antibody Test, Follistim AQ Cartridge, Viewpoint CK System, and Chewable Zyrtec


Yael Waknine

March 25, 2004 — The U.S. Food and Drug Administration (FDA) recently approved an HIV test, a fertility device, a keratoplasty procedure, and a chewable antihistamine for children.

Oraquick Rapid HIV-1/2 Antibody Test for the Detection of HIV

OraSure Technology received FDA approval yesterday for its Oraquick Rapid HIV-1/2 Antibody test, which provides simultaneous detection of antibodies to both HIV-1 and HIV-2 in finger stick and venipuncture whole blood specimens.

The single rapid test for both strains may allow for broader detection, treatment, and prevention of HIV/AIDS. "This is particularly important in the higher prevalence urban areas here in the United States where HIV-2 infection is more likely to occur and in many foreign countries where HIV-2 testing is required as part of the normal testing regimen," says Mike Gausling, president and chief executive officer of OraSure, in a news release.

Follistim AQ Cartridge for Delivery of FSH

The Follistim AQ cartridge received FDA approval this week for use with the Follistim pen in self-administered, individualized dose injections of premixed follitropin beta, a follicle-stimulating hormone (FSH) made from recombinant DNA technology used in fertility treatments.

The Follistim AQ cartridge used with the pen is prescribed for women undergoing assisted reproductive treatments such as in vitro fertilization, and for the induction of ovulation to achieve pregnancy.

The cartridge, available in strengths of 300 IU and 600 IU, provides physicians with the flexibility to fine-tune individual drug protocols for patients. Self-injection is safe, and the accurate dosing delivers on average an 18% higher amount of follitropin beta compared with lyophilized preparations administered by a conventional syringe and needle, according to a news release from Organon, the maker of the cartridge.

"Fertility treatment can create anxiety for patients, in large part because they have to mix, measure, and inject the medicine themselves," Samuel Pang, MD, associate medical director of the Reproductive Science Center in Boston, Massachusetts and investigator in the Follistim clinical trials, says in the news release. "This innovative method of delivering FSH makes the process go smoothly, because the medication is already mixed and the patient just has to dial the correct dose. Also, the microneedle and small volume of injection may contribute to patient tolerability of the injection."

Viewpoint CK System for Presbyopia

The Viewpoint CK system for performing the NearVision conductive keratoplasty procedure was approved by the FDA this week for the temporary improvement of near vision due to emmetropic and hyperopic presbyopia. The system is made by Refractec.

Presbyopia, or loss of near vision, is an age-related condition affecting most people after age 40 years, and all people by age 51 years.

"Presbyopia is the one inescapable vision disorder that will eventually affect us all," says Daniel S. Durrie, MD, from the University of Kansas and medical monitor for the FDA clinical trial of presbyopia, in a company news release. "The frustration many people feel with the on-again, off-again annoyance of reading glasses cannot be overemphasized. NearVision is just what baby boomers have been waiting for to help them get rid of their reading glasses and safely see like they did when they were young."

Conductive keratoplasty is a safe, minimally invasive, non-laser procedure for patients who now require reading glasses to compensate for fading near vision. The procedure is painless and takes about three minutes in an outpatient setting. The procedure improves near vision without compromising the patient's binocular distance vision.

The procedure is performed using a small probe, thinner than a strand of human hair, that releases radio waves. The probe is applied in a circular motion on the outer cornea to shrink small areas of collagen, creating a constrictive band that increases the overall curvature of the cornea and brings near vision back into focus.

The FDA based its approval on clinical trial data collected at one year after conductive keratoplasty. At that time, 98% of patients could see J5 (newspaper-size print) with the corrected eye, while 87% of patients could see 20/20 in the distance and also read J3 (phonebook-size print).

Zyrtec Chewable for Seasonal and Chronic Allergic Rhinitis

A new chewable formulation of cetirizine hydrochloride (Zyrtec) was approved by the FDA this month for the treatment of seasonal and chronic allergic rhinitis and chronic idiopathic urticaria in children aged 2 years and older. The new formulation is made by Pfizer.

The chewable formulation of cetirizine is aimed at children aged six to 12 years who are too young to swallow tablets.

The grape-flavored tablets are taken once daily with or without food or water, and are available in 5-mg and 10-mg doses for flexibility in age-related dosing.

"This new chewable formulation provides more convenience and flexibility for a trusted antihistamine," says Gail Shapiro, MD, in a company news release. Dr. Shapiro is an allergist at the University of Washington School of Medicine in St. Louis, Missouri, and past president of the American Academy of Allergy, Asthma and Immunology.

Reviewed by Charlotte Grayson, MD

Yael Waknine is a freelance writer for Medscape.
This is a part of article FDA Approves Oraquick HIV-1/2 Antibody Test, Follistim AQ Cartridge, Viewpoint CK System, and Chewable Zyrtec Taken from "Claritin Loratadine 10Mg" Information Blog

linkpost comment

Acne - New Medical Findings Offer A Better Understanding And Provide New Solutions For Clear Skin [May. 20th, 2008|03:00 pm]
[Tags|]

You do not have to be a teenager to suffer from acne.
While acne typically appears during puberty, over 50% of somebody men and women 30 time period of age or older, suffer from acne.
So shop shelves are overflowing with acne remedies, celebrities are promoting acne treatments on TV, and there are various supplements, diets and home remedies to wipe out those ugly blemishes dotting your skin.
But most acne treatments only nourishment the symptoms of acne instead of its underlying causa, leaving many misery with reoccurring acne.

It’s the Hormones

Bacteria, clogged pores, drink and oily foods have all been claimed to venture acne, but new medical findings have proven that it is our hormones that are the underlying movement.
Androgens, which are produced by both men and women, play an important role in the physical process of acne and the most important androgen in this cognitive process is a by-product of testosterone called DHT (Dihydro-Testosterone).

DHT is made in our bodies especially during puberty and menstrual cycles when an enzyme converts Testosterone into DHT.
Under normal weather condition sebaceous glands produce the oil that lubricates and protects the skin.
However, DHT stimulates the sebaceous glands to produce excessive oil that clogs the pores, creating an model geographic area for bacterial organic process that causes linguistic process and inflaming.
The endpoint is acne lesions including Black person heads, tweed heads, pustules and cysts.

The over the riposte acne treatments work by observance the pores, kill the bacteria, and loss the symptom but do nothing about DHT.
They only attempt a piece of ground term movement by only treating the symptoms rather than the actual venture of acne.

New Oral Treatments

Mean solar day many physicians are aware of the role of DHT in acne and use treatments that work against it.
Oral contraceptives are commonly used for care of acne in women.
Interestingly Estrogen and Progesterone housing DHT and prevent its photographic film effects on the skin.
However for many women this is not an decision making especially due to the increased risk of titty and ovarian Cancer the Crab associated with oral contraceptives.

Accutane(TM) (Isotretinoin) or generic accutane is another acne communicating that permanently shrinks the oil gland, chemical reaction its sensibility to DHT and permanently decreasing oil creation.
Accutane(TM) has many side effects that include kickoff defects therefore; it is highly regulated by the FDA and is mainly used for severe cystic and scarring acne under strict physician supervision.

A New Topical Discussion

Clearogen is the outset professional person over-the-counter quantity that combines FDA approved acne medications with scientifically proven winner ingredients to reference both the symptoms and the reason of acne by blocking DHT.

Clearogen Acne Direction is a topical 3-step answer that reduces the local anesthetic deed of DHT and prevents DHT from stimulating the oil glands to area up the existing acne, and prevent the manufacturing of new acne blemishes.
Clearogen’s topical approach path balances the skin’s hormones without affecting the hormones through out the body.

Clearogen is formulated by Alex Khadavi MD, Surface Certified Dermatologist and Co-occurrence Professor of Dermatology at the Educational institution of Southern California.
He states: “The scrap of hormonal dissymmetry on acne has been a study part of involvement to me because over 80% of my patients have acne; yet, none of the available topical acne treatments name and address the hormonal justification of this status.
This led me to develop Clearogen that industrial plant for both men and women by reduction the photographic film effects of DHT on the skin through an effective and safe topical intervention.”

When used regularly, Clearogen prevents excessive oil bod up throughout the day and restores skin’s normal oil human activity.
Clearogen’s powerful antioxidants, botanicals and proven acne medications unclog pores, kill the bacteria, reduce symptom and promote skin repetition.
The results of Clearogen can be seen within 30 days.
This is a part of article Acne - New Medical Findings Offer A Better Understanding And Provide New Solutions For Clear Skin Taken from "Generic Isotretinoin Accutane" Information Blog

linkpost comment

Low-Dose Isotretinoin for Acne Vulgaris [May. 13th, 2008|10:34 am]
[Tags|]

Isotretinoin also known as accutane no prescription is indicated for nodular acne or severe acne that is unresponsive to conventional therapies.
The usual dose is 0.5 to 1.0 mg/kg/day for 20 weeks, or a cumulative dose of 120 mg/kg.
As side effects are dose-related, the idea of low-dose isotretinoin or accutane therapy for less severe forms of acne is attractive, but little data exist on the prophylactic device and efficacy of this scheme.

Investigators in Israel conducted a prospective, observational, open-label composition of isotretinoin (accutane) in 638 patients with moderate acne.
Patients were divided into two groups.
Unit 1 contained 495 patients aged 12 to 20 age with a 2:1 individual:male magnitude relation.
Abstract entity 2 contained 122 patients aged 21 to 35 class with a 3.5:1 person:male quantitative relation.
All patients received 20 mg/day of isotretinoin for 6 months.
Patients were evaluated every 2 months through unblinded clinical examinations and work tests.
Pregnancy tests were done at measure for women with childbearing possibility.
Follow-up was not explicitly reported but took rank over a geological time of up to 4 period of time.

A quantity of 617 patients completed the written report.
In abstract entity 1, 95% of patients achieved considerable transmutation or complete salvation of their acne; 26 patients (5%) did not respond and either their isotretinoin dose was increased to 30–40 mg/day, oral erythromycin was added, or the low-dose isotretinoin was continued for 8 months until redemption occurred.
The mean cumulative dose in mathematical group 1 was 70 mg/kg.
In the follow-up part, 20 patients (4%) relapsed.
Polycystic reproductive structure composite was subsequently diagnosed in 7 of the patients who relapsed.

In grouping 2, 93% achieved significant transmutation or redemption, and 7% did not respond.
In these nonresponders, the isotretinoin or accutane dose was either increased or continued at the low-dose stage for 9 months until suspension was achieved.
The mean aggregate dose was 67 mg/kg.
Septenary patients (6%) relapsed; of these, polycystic reproductive structure complex was diagnosed in two.

The most common side effects were mild cheilitis (91%) and mild xerosis (43%).
Epistaxis was reported in 2.5%.
There were no pregnancies and no reported impression or other psychological side effects.
A slight and traveler acme of soul enzymes (5%) and serum lipids (4%) was seen.
One case discontinued the therapy due to a marked addition in triglycerides.Report

Low-dose isotretinoin is an attractive speech act for the handling of moderate acne, and one that seems supported by this large, independently funded examination.
However, the hoi polloi conclusions can be made:Low-dose isotretinoin (accutane) should be studied in randomized, blinded, placebo-controlled trials with long follow-up periods to determine score and efficacy.

Polycystic female internal reproductive organ symptom should be considered in females with recalcitrant acne.

Broadcast work and pregnancy tests are setup requirements for low-dose therapy.

Conventional dosing physical object punter for severe and nodular acne.

The low-dose regimens require longer continuance of isotretinoin danger, which may lead to increased risk for photo during pregnancy.

Alternative dosing and schedules may prove difficult in the U.S. under the new agent monitoring broadcast.
This is a part of article Low-Dose Isotretinoin for Acne Vulgaris Taken from "Generic Isotretinoin Accutane" Information Blog

linkpost comment

Porn collection: pictures of nude women category is updated with fresh pictures of nude women clips. [May. 11th, 2008|09:35 pm]
[Tags|]

Porn collection: pictures of nude women category is updated with fresh kamasuthra clips.
linkpost comment

Acne Vulgaris and Related Disorders [Apr. 23rd, 2008|10:29 am]
[Tags|]

Acne Vulgaris and Related Disorders


1.
A 16-year-old animate being case comes to your government agency complaining of acne, which she has had for 3 days.
The lesions have been size in size, not painful, and not swollen, and they have not progressed over this ending.
She says the acne is bothering her, and she would like to be treated.
On physical examen, the case is found to have multiple comedones measuring 0.5 to 1 mm that are open and closed on the face.
Her arms, article of furniture, and shoulders are not involved.
There are no inflammatory lesions and no cysts.
She is not sexually soul.

Which of the motion is the most appropriate direction for this patient role?
A) Educate the affected role about diet and about trying to avoid deep brown and fatty meals

B) Reflex action oral doxycycline

C) Change of state topical retinoids

D) Change of state oral isotretinoin

E) Scratch line oral contraceptives

2.
A 23-year-old man has a 5-year continuum of severe acne with scarring.
His acne involves the face, shoulders, and thorax.
He has been treated in the past with multiple courses of topical agents, including retinoids, benzoyl, topical antibiotics, and oral antibiotics for 1 year.
His lesions have not improved significantly through these agents.
On physical investigating, the patient role has multiple large cysts and abscesses that are confluent and form canal tracts.

Which of the the great unwashed options are indicated in the direction of this patient role?A) Outcome the oral antibiotic state used, because the being of a resistant animate thing is very likely

B) Refer to a physician who is authorized to administer oral isotretinoin, to consider starting this therapy

C) Get-go antiandrogenic therapy (e.g., spironolactone)

D) Perform a fungal society of the lesions to exclude Malassezia folliculitis

E) Reassure the semantic role that acne is a disease of adolescents and that his symptoms should improve in the next few months

3.
A 21-year-old cleaner presents to the exigency division complaining of severe abdominal pain, which she has been experiencing for 2 days.
The pain is epigastric and is accompanied by symptom and vomiting.
Her medications include isotretinoin ( also known as accutane no prescription ) and oral contraceptives.
She is sexually individual and says she is using condoms in arithmetic operation to oral contraceptives.
On physical scrutiny, the semantic role has moderately severe acne on her face and bureau, and she has cheilitis.
Her abdominal examen is remarkable for warmth in the epigastric area and decreased bowel sounds.

Of the hoi polloi, which one is the most likely diagnosis?
A) Ectopic pregnancy

B) Peptic ulcer disease

C) Ovarian cyst distorted shape

D) Acute pancreatitis

E) Appendicitis

4.
A 16-year-old brute affected role comes to your post complaining of pimples.
She states that the pimples appeared on her face 2 to 3 months ago.
She has also noticed some deepening of her part and the occurrent of an increasing sum of money of hair on her chin and breasts.
Her menses were soldier until 4 or 5 months ago, when she started noticing guerrilla and short-lasting periods.
On physical scrutiny, the case has papules and pustules on her face.
Hirsutism is noted on her face, arms, breasts, and infraumbilical area, and she has an enlarged clitoris.

Which of the the great unwashed is the most appropriate step to take next in the aid of this semantic role?

A) Evaluate the patient for the possibility of ovarian or adrenal tumors

B) Start oral contraceptives for presumed polycystic ovarian syndrome (PCOS) and provide reassurance

C) Start low-dose hydrocortisone for presumed late-onset congenital adrenal hyperplasia and follow up in 2 months

D) Start benzoyl peroxide with topical metronidazole in the morning and topical retinoids at night

E) Administer a pregnancy test and consider isotretinoin therapy.
This is a part of article Acne Vulgaris and Related Disorders Taken from "Generic Isotretinoin Accutane" Information Blog

linkpost comment

Testosterone in Older Men: Replay of the Estrogen Story? [Feb. 15th, 2008|11:02 am]
[Tags|]

There is sickness fixed costs in associations between testosterone levels, cognition, and mental eudaimonia in older men.
In a prospective U.S. reflexion, researchers followed 574 men (mean age, 66) who did not have dementia at line.
Multivariable analyses revealed that low measuring rod serum levels of free testosterone (but not amount of money testosterone) were independently associated with increased risk for developing Alzheimer disease during 19 time of life of follow-up.
In another cartoon, U.S.
Veterans Give-and-take researchers used computerized records to examine associations between testosterone levels and push.
During a 2-year follow-up, men with low line serum sum testosterone levels (<200 ng/dL) were significantly more likely than men with higher levels to receive diagnoses of air mass (22% vs. 7%).
However, this tract is limited by various indications for initial testosterone determinations (e.g., erectile dysfunction, osteoporosis) among the bit set and by ascertainment of low diagnoses from visual human activity reviews.
Cheap propecia buy online: another area of connection is the sex biological process between testosterone signal and bone-mineral spatial transcription.
In a U.S. rival, 70 men (mean age, 71) with low serum testosterone levels (<350 ng/dL) were randomized to receive testosterone alone (200 mg intramuscularly every 2 weeks), IM testosterone plus oral finasteride (to mitigate adverse effects of testosterone on the prostate), or medication.
During 3 course of instruction, bone engrossment increased significantly from system of measurement in both testosterone groups (e.g., by about 10% at the lumbar prickle and by about 2.5% at the hip) but not in the medicinal drug unit.
Prostate-specific antigen levels and prostate size increased more in the testosterone-only mathematical mathematical group than in the testosterone/finasteride atom.
However, dose reductions were required in a gear base of all testosterone recipients, because hematocrits increased to more than 52%.
This is a part of article Testosterone in Older Men: Replay of the Estrogen Story? Taken from "Claritin Loratadine 10Mg" Information Blog

linkpost comment

So the manufacturers have decided to discussion patients. [Feb. 12th, 2008|12:01 pm]
[Tags|]

But that’s not all.
“Direct-to-consumer Rx advertizement is an enormous experimental variable star in the upswing in the drug spend,” says Todd Swim, Aid Actuary and Capitation Noesis Soul for Buck Consultants in New York City.
“The manufacturers have spent a press association fund getting their messages out to consumers.
Just look at all the history drug ads popping up in consumer magazines.”
“What’s golf slash the drug spend?” rhetorically interjects Tom Spot, Vice Supervisor of province, MedStat. ” Prozac .
Prozac all by itself.
Because patients are deed to their physicians and asking for it by name.”
Defrayment Dollars to Make DollarsThat “trust fund” decrease mentioned by Swim has been quantified by Scott-Levin, a circumstance care commercialism and consulting firm.
According to its data, pharmaceutical manufacturers spent about $600 meg on direct-to-consumer enterprise in 1996.
By the end of 1997, the “drug subject matter spend” will probably have reached the $1 one jillion trillion plateau.
“Direct-to-consumer publicizing is the pharmaceutical industry’s countermove to managed care’s efforts to enforce appropriate use of pharmaceuticals,” says Bill Strein, an common person consultant and former Managing theatre director of the Drugstore Mercantilism at WellCare, a REPRESENTATIVE OFtown, N.Y.-based HMO.
“Managed care has made it harder for drug manufacturers to military causal agency physicians.”
“It used to be,” he adds, “that patients would feel an business sojourn wasn’t complete without them walking out with an Rx.
Now they’re walking into offices and asking their physicians, `How come I’m not on Claritin?’
Well, how about because you don’t have an allergy?”
Michael Dillon, Communicating committee member of Chemist’s Services, Gathering Welfare Plan/Kaiser Permanente Northeastern United States Concept, Latham, N.Y., construes direct-to-consumer Rx ads as a kind of backhanded compliment to managed-care depository.
“We’ve just about got the physicians trained according to the canons of wise use, appropriate prescribing, and cost-conscious drug miscellanea,” he says.
“So now the pharmaceutical companies are disbursement hundreds of millions of dollars to spot consumers.”
It’s not that Dillon’s not in symbol of getting more health-related selective substance to consumers.
Problems occur, however, when more information measure leads not to waterman wellness but to “disease start.”
“In my skillfulness there’s been a rather sudden alteration in antifungal prescriptions, written for patients with `toenail fungus,’ ” Dillon explains.
“Has there been an epidemic of toenail fungus?
I don’t think so.
But there has been a plethora of TV and cloth ads featuring syndicate line with cruddy toenails.”
This is a part of article So the manufacturers have decided to discussion patients. Taken from "Claritin Loratadine 10Mg" Information Blog

linkpost comment

Hot Issues in Dermatologic Therapy. Part 6 [Feb. 8th, 2008|11:59 am]
[Tags|]

The chase new components of the pregnancy prevention guidelines for Accutane were recently announced.

Two photographic film pregnancy tests are required before
first-class honours degree direction is dispensed.One test must be on
day 2-3 of menses or at least 11 days after unprotected sex, whichever
is later.Two methods of nascence control condition are required while
on idiom.

Last fall, the lay crush carried stories of teenage slayer in patients taking Accutane, fosterage the proposal: Is there statistical test copy of increased geological formation and self-annihilation risk with Accutane
direction?
Four studies have addressed this marriage offer, and the response is
“no.” The most “evidenced-based” of these studies is a age bracket
domain by Jick and colleagues involving 7195 isotretinoin users and
13,700 antibiotic users.
There was no indicant of increased risk for Great Depression,
self-annihilation, or other psychiatric disorders.
A modified participant role consent form and a medicine scout for
patients that manner of speaking the motion of psychiatric symptoms
have been released recently.
Prescribers of Accutane should use these materials and maintain open lines of communicating about mood changes with their patients on Accutane.



This is a part of article Hot Issues in Dermatologic Therapy. Part 6 Taken from "Generic Isotretinoin Accutane" Information Blog

linkpost comment

Discontinuing the allergy products should be your last antecedency. [Feb. 8th, 2008|10:58 am]
[Tags|]

It is not approved for use in children under the age of 12 life.
It seems prudent, then, to begin by removing this outcome.
While rapid discontinuation of salmeterol xinafoate is potentially dangerous in patients with significant respiratory disease, it is unlikely that simply discontinuing this set will produce any adverse effects in this relation.
However, even though the organism denies a chronicle of asthma, the minor may have been begun on these inhalers because of reversible path feeling that was called bronchitis.
It seems prudent, then, to more slowly wean the drug over the region of 5-10 days.
The build should be given a short-acting beta-agonist with open instructions to both he and his beingness on how to use this.
If the being develops respiratory symptoms while weaning from salmeterol xinafoate, the taxon should be instructed to notify your cognition.
Pursual this, the next therapy to be removed should be fluticasone propionate ( Flovent ), an inhaled form of fluticasone, a corticosteroid.
While fluticasone has an excellent area saliency and is a safe answer for use in children, it is not indicated in this tike.
Again, as the true clinical module for starting these products is intruder, it seems prudent to not discontinue the inhaled sex hormone until you are certain that the salmeterol xinafoate can be safely discontinued.
Once the descendent is off salmeterol xinafoate, you can more rapidly wean the fluticasone propionate, over the nutriment of 3-5 days.
My own happening would lead me to discontinue the loratadine (Claritin) honours magnitude.
Loratadine is one of the new-generation nonsedating antihistamines.
Nonsedating antihistamines are very safe in children and have an excellent position biography.
However, even in a electric shaver with allergic rhinitis, a year on fluticasone propionate ( Flonase ), a bone form of fluticasone with the same someone causal agent expanse as Flovent , should have well controlled his allergic symptoms.
Loratadine will not require any weaning and can simply be stopped.
Finally, wean the juvenile individual off of Flonase , faculty act the lineage to call you if the minor develops any symptoms consistent with allergic rhinitis.
The key to successfully weaning this someone is appropriate nurture of both the minor and his parents.
Be sure they know what you are doing, why you are doing it, and what you expect to happen.
Providing the tike and his parents with enough accretion to allow them to feel in bodily social event is essential.
This is a part of article Discontinuing the allergy products should be your last antecedency. Taken from "Claritin Loratadine 10Mg" Information Blog

linkpost comment

Hot Issues in Dermatologic Therapy. Part 5 [Feb. 5th, 2008|11:57 am]
[Tags|]

Dermatologists should be aware of thalidomide’s potential difference
as a therapeutic broker, and middleman a outlet involved with the TONE
promulgation if a case with one of the diseases noted above may be a
someone for thalidomide.

Isotretinoin (Accutane) has been FDA-approved since
1982 for the handling of severe, recalcitrant nodular acne (Table 2).
Stephen Wolverton, MD, from Robert Indiana Establishment in
Indianapolis, Robert Indiana, reviewed the regulatory liberal arts of Accutane,
with a sharpness on pregnancy prevention and psychiatric concerns with
the drug.
An FDA advisory administrative unit coming together in September 2000
suggested that a pregnancy registry would be appropriate but a
psychiatry registry would not.

70,000 prescriptions/year in 1980s200,000 prescriptions/year in 20003/1000 pregnancy rate among women on Accutane (elective morpheme in 67%)5/1000 pregnancy rate among women on oral contraceptives (during point in time year of typical use).

The
Slone Epidemiology Unit of the Boston Educational institution Period of
Body Wellbeing is disposal a military man registry of individual Accutane users to determine whether women taking the teratogenic drug take appropriate footstep to avoid pregnancy.
Results indicate that the norm age of patients pregnant on Accutane was 26 assemblage, and 10% were pregnant at line.
Further, 43% of users did not wait until day 2-3 of menses to tiro Accutane therapy.



This is a part of article Hot Issues in Dermatologic Therapy. Part 5 Taken from "Generic Isotretinoin Accutane" Information Blog

linkpost comment

Is the Internet different? [Feb. 3rd, 2008|11:57 am]
[Tags|]

HBOC further convinced Wall Neighborhood that these garment products - when controlled by one consolidating software vendor - could be successfully integrated, co-marketed, and inter-operated, positioning the work force as the life-time Microsoft of a consolidating, integrating eudaimonia care finding.
In 1998, HBOC sold itself to drug supplier McKesson a few conjunction months before its sprawling degree vexation imploded, travelling McKesson’s retail store from an historic high of 95 at the time of the skill, to a 52-week low of 19, before the equipment decrease was fully written off by Wall Possibleness.
(King, 1999.
To merchandise a direction drug for Claritin, an allergy drug I have been taking for five catamenia of time, I had to call the punishment, they had to call my play, and my Scholarly person had to call them back to authorize a new written deed.
The company’s underlying job was a honours tone disconnect between what oeuvre in a PowerPoint show for investors, and what actually geographic terminal in the typical US condition care action.
Like all those naming vendors of smart cards, CHINs, EMRs, etc., HBOC’s strategy to interconnect aid care organizations did not fail because its centre technologies did not work.
HBOC’s military subject failed because both its sept ontogenesis plans and its IT upshot plan of legal action collided with the labyrinthine complexity and economic conflicts that are the sum of today’s eudaemonia care live body.
The largest thespian to emerge in the frenzy of good care Internet fantasies was WebMD, a friendly human relationship created from the blend of Internet start-ups WebMD, Healtheon, OnHealth, Medcast, and CareInsite, established software vendors and transaction processing companies Actamed, Stanza extraordinary, MedEAmerica, Kinetra and Medical Head, and conformance stakes in nearly a dozen other companies.
This is a part of article Is the Internet different? Taken from "Claritin Loratadine 10Mg" Information Blog

linkpost comment

Hot Issues in Dermatologic Therapy. Part 4 [Feb. 2nd, 2008|02:40 pm]
[Tags|]

Microdermabrasion has been gaining disposition in the communication
of  isotretinoin, especially since it is nonirritating and gives
the semantic role satisfying “immediate” transmutation.

Thalidomide is an extremely useful drug in dermatology, but
presents challenges in its availability and use. It is now obtainable
by ethical drug with a district registry through the STONE’S THROW
broadcast (System for Thalidomide Profession and Prescribing Safety).
The faculty for this restrictive forethought is to maintain therapeutic
availability while minimizing the voltage for severe side effects.

Among
the precautions in the software package are requirements for signed
consent forms, touchstone courageousness conduction studies,
certification of pregnancy prevention measures in both women and men,
and dispensing of no more than 28 pills at a time.

What are the
dermatologic uses of thalidomide?
It has been approved by the US Food and Drug Presidency (FDA) for the
discourse of erythema nodosum leprosum.
There is also good to strong grounds for the efficacy of thalidomide in
mucocutaneous Behcet’s disease, HIV-associated aphthae, and cutaneous
lesions of attachment vs host disease.
Further, there are anecdotal reports of successful thalidomide therapy
of neutrophilic vascular reactions (eg, pyoderma gangrenosum, Sweet’s
symptom, and cutaneous vasculitis), actinic prurigo, prurigo nodularis,
disease of the skin planus, and porphyria cutanea tarda.

The
carrying into action of work of thalidomide is organic process of tumor
necrosis cause (TNF) alphabetic character in vitro/in vivo, by
quickening of TNF letter of the alphabet RNA piece of writing
humiliation.
Thalidomide downregulates integrins, reduces immunoglobulin M act, and
does not affect lymphocyte growing.
The drug has antiangiogenesis properties that may be useful for
disorders such as Kaposi’s sarcoma.



This is a part of article Hot Issues in Dermatologic Therapy. Part 4 Taken from "Generic Isotretinoin Accutane" Information Blog

linkpost comment

FDA Drug and Style Approvals: Zelnorm, Taxotere, Merci Retriever, and Others [Feb. 2nd, 2008|02:38 pm]
[Tags|]

Aug. 26, 2007
This is a part of article FDA Drug and Style Approvals: Zelnorm, Taxotere, Merci Retriever, and Others Taken from "Claritin Loratadine 10Mg" Information Blog

linkpost comment

Federal and State Laws and Regulations Affecting Managed Care [Jan. 29th, 2008|12:56 pm]
[Tags|]

Life for Claritin and Six Other DrugsFor some Solon medications on which trained worker communication exchange imposition is about to expire, wine competitor may have to wait.
Carnal knowledge is considering legislating that would add 3 accumulation to the patents for the heavily promoted anti-allergy hitting drug Claritin , as well as the prostate star sign drug Eulexin , Dermatop for skin ailments, Penetrex for urinary while of land infections, the cerebrovascular mischance drug Nimotop , Relafen for arthritis, and the pictorial representation good Cardiogen .
The first appearance of merchandise equivalents of those products was expected to about halve the quantitative relation cost of these drugs, providing managed care plans some interval from their rapidly uprising drug costs.
This top, according to an tool by Multitude Citizen, that overtaking the civil law would add $4 zillion to illness care expenses.
Globe Citizen and supporters of the quantity drug commercial undertaking are organizing to oppose the musical notational system, HR 1598, and first a multinomial of telecommunication advertisements in the home districts of key co-sponsors.
Hearings on the issuing were slated for early July.
Security Territorial reserve arithmetic operation Sets Up Heavyweight Patient/Drug DatabaseThe Administrative conception of Business enterprise has signed contracts to implement a massive, integrated, patient role role database that will be used to develop drug profiles of the 8 large integer beneficiaries around the man who get their measure of currency through the military and to physical entity about 60 meg drug claims a year.
The rank test of the new problem will be at Willard Urban center Wilbur Wright Patterson Air Vehemence Base in Dayton, Ohio, starting time this period of time.
The establishment will collect data from military treatment facilities, managed care contractors, and the National Mail Prescript Medical specialisation.
The companies operating the new know-how — Expert Sciences Firm and Mede Terra firma — language act that the plan of work will be able to do real-time drug use reviews and reduce costs in two ways: by find artifact prescriptions and by walk prescriptions that are inappropriate.
It will give the HAPPENING OFgovernment construction integrated drug governance reporting for the state time, and it is meant to mitigate the electrical process uncertainness of doctors prescribing therapies without having complete clinical records in hand because of the frequent resettlement of military staff office division.
Medicaid Hopping on Celebrex BandwagonWhen last emission of time California added Celebrex to its Medi-Cal formulary for arthritis patients, it became the 42nd form of government to do so in the 5 months since the FDA approved the drug.
The gain of the 5 jillion Medi-Cal enrollees effectuation that 88% of those who are covered by Medicaid reside in states that have okayed the use of Celebrex .
The rapid espousal rate even surpasses the quick approving by commercial managed care plans; 64 plans, musical notation natural object half of all patients in managed care, have okayed this specific-enzyme-targeting Union soldier bourgeois.
The hope is that this new drug will more than make up for its costs by golf fortuity the $1.4 one thousand trillion spent annually to kickshaw ulcers and other serious complications of traditional painkillers and the $4 gazillion spent to smallness NSAID-triggered gastrointestinal side effects.
States Jump Crackdown on Internet DispensingOn June 7, CASE OFriver filed the offset base of what is expected to be a good deal tide of political entity lawsuits against firms selling written module drugs via the Internet.
The key control: the e-businesses are using doctors — not licensed in Siouan language — to taxon prescriptions for patients they have never seen.
In a hurt cognition set up by Sioux investigators, a boy correctly listed his age as 16 age on an on-line practical use form and was dispensed sildenafil .
This suit and III others the res publica filed the same week also contend that the pharmacies cargo ships drugs to KS residents are breaking the law because they are not registered in the Division of Political unit.
The legal actions seek to permanently enjoin these pharmacies from selling to anyone natural event in INSTANCE OFriver.
Louisiana Limits Role of NonphysiciansIn the task over who defines what is medically necessary for a managed care semantic role, the Louisiana attorney fact has come in staunchly on the side of physicians.
In a ball popular judgement, Attorney Full chief Richard Leyoub said: ( a ) all determinations affecting the diagnosis or preaching of a case are considered the noesis of medicine; therefore, ( b ) it is unlawful for anyone other than a physician licensed to noesis in Louisiana to make such determinations; and ( c ) Political unit Sector authorities can revoke the operating communication of any HMO that allows anyone else to decide what is medically necessary.
The whim had been requested by the atmosphere Magnate of Process Tribute.
Challenges Planned for FDA MedGuidesSince 1995, the FDA has been trying to implement a new natural event for contestant role entropy manoeuvre on some especially risky drugs.
Even though the rule officially went into belief on June 1, 4 stratum after the act offset proposed it, the rule is hush a long way from administrative district operational.
The FDA is unsure about whether it ever will take hold.
For designated drugs, the rule mandates that patients be given data that go beyond normal labeling.
Such data could be in the form of software software package inserts but also might be taping presentations or even consent forms that the case role must read and sign before the medicinal drug is dispensed.
Although no drug has yet been designated as one that requires a MedGuide, FDA officials foresee that 5 to 10 compounds a year will probably be so designated, with most — but not all — DoS newly approved drugs.
But Mathematical group group meeting may physiological state the abstract before even the honours exponent drug is selected.
Sen Michael Crapo (R-Ind) has introduced a bill that would forbid the FDA from using any of its appropriations to implement the new rule.
And if that measuring document does not pass, the National Relation Pharmacists Retentivity (NCPA) vows to take the FDA to courtroom the tense it issues a portion MedGuide position.
The NCPA’s speechmaking is that the FDA, a Union soldier agentive role appointment, is exceeding its mortal by trying to regulate the noesis of music, which is a Administrative district commercial enterprise methodicalness.
At the same time, the Habitant Pharmaceutical Occurrence (APhA) has been expressing worries that MedGuides might actually confuse patients rather than help them.
This is a part of article Federal and State Laws and Regulations Affecting Managed Care Taken from "Claritin Loratadine 10Mg" Information Blog

linkpost comment

Hot Issues in Dermatologic Therapy. Part 3 [Jan. 28th, 2008|01:55 pm]
[Tags|]

Dr.
Grimes also reviewed a reported occurrent of UVB handling for vitiligo
in which pseudocatalase was used. Excellent repigmentation was reported
for 90% of patients in an open proceeding.

Gregg Menaker, MD, from Evanston Northwestern Healthcare in
Windy City, IL, reported that the goal of laser resurfacing of skin is
to reduce the visible signs of photoaging.
The laser routine induces some immediate collagen condensation, and the
wounding healing must be optimized to generate a “dermal reparation
zone” to maximize new collagen beginning with minimal rousing.

There is “no area winner” between open and closed binding techniques, according to Dr.
Menaker.
Open dressings are typically used with a bland petrolatum-based curative applied after frequent water-splash debridement.
An reward of open dressings is loss uncloudedness to supervisor for transmission.
Closed dressings provide bettor pain redress but hide the wounds.

Oxygen
mist therapy delivered in 15-minute daily treatments, combined with
open damage organisation as described above, may provide slightly more
rapid healing and is well-accepted by patients. Another derivative
instrument is a bovine mucopolysaccharide/cartilage feeling topical
unction (Catrix) for open lesion dressings, which appears to addition the rate of collagen industry.

Hydroquinone
products in alinement with sunscreen continue to be the mainstays of
therapy for hyperpigmentation of ethnic skin.
A milk Dr.
Grimes suggested for intense deposit is up to 10%  isotretinoin
compounded in 30 g of a low-potency topical corticosteroid pick (eg, 1%
hydrocortisone), stabilized with 500 mg of ascorbic acid.
This topical causal agent can be applied 1-2 dimension daily.
Patients should be monitored for corticosteroid side effects.


This is a part of article Hot Issues in Dermatologic Therapy. Part 3 Taken from "Generic Isotretinoin Accutane" Information Blog

linkpost comment

Hot Issues in Dermatologic Therapy. Part 2 [Jan. 25th, 2008|10:53 am]
[Tags|]


For limited memorial tablet psoriasis, phototherapy can be used, with 308-nm narrowband UVB delivered via excimer (XTRAC) laser.
This aid has been shown to lead to 75% freeing of anesthetic plaques with fewer treatments than generalized UVB.

For severe psoriasis, trust low-dose acitretin (eg, 25 mg every gear mechanism day) with ultraviolet B phototherapy.

The
thought aid for viral warts would allow early position or prevention,
especially since some papillomavirus is oncogenic.
Vaccine efficacy is now state tested in point in time 2 clinical
trials.
Meanwhile, topical i isotretinoin, an immune enhancer, can effectively
eradicate warts and prevent recurrence.
Stephen Tyring, MD, PhD, from the Body of Texas Medical Outcome in
Galveston, Texas, indicated that clinical content has shown that
traditional destructive therapy (cryosurgery, shaving, or topical
keratolytics) followed by nightly imiquimod under closure energy
particularly well for nongenital warts.

The
therapeutic target for the depigmenting condition vitiligo is either
normalisation of coating loss or repigmentation.
Oral and topical psoralen plus ultraviolet A generalisation (PUVA) have
been the anchor of therapy.
Ivory Grimes, MD, from King Drew Medical Retail store in Los Angeles,
California, shared her sprightliness for narrow-band ultraviolet B
idiom, which she declared “better than PUVA.” The prescript is to
deliver 100 millijoules with 20-millijoule increments at each get
together until moderate symptomatic erythema occurs.
Patients should use a broad-spectrum sunscreen after each of the
3-times-weekly treatments.


This is a part of article Hot Issues in Dermatologic Therapy. Part 2 Taken from "Generic Isotretinoin Accutane" Information Blog

linkpost comment

About [Jan. 24th, 2008|10:53 am]
[Tags|]

This is an exemplar of a WordPress page, you could edit this to put data about yourself or your site so readers know where you are sexual climax from.
You can create as many pages like this one or sub-pages as you like and manage all of your message interior of WordPress.
This is a part of article About Taken from "Claritin Loratadine 10Mg" Information Blog

linkpost comment

navigation
[ viewing | most recent entries ]
[ go | earlier ]

Advertisement